U.S. market Closed. Opens in 17 hours 15 minutes

CUE | Cue Biopharma, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
Revenue5.49M1.25M14.94M3.15M3.46M1.14MN/AN/AN/A
Cost of Revenue3.44M1.81M-1.78M33.55M27.49MN/AN/AN/AN/A
Gross Profit2.05M-560.83K16.72M-30.39M-24.03M1.14MN/AN/AN/A
Operating Expenses54.05M54.75M58.65M48.20M40.23M39.84M23.23MN/AN/A
Selling, General & Admin13.77M16.17M17.31M14.65M12.74M11.30M4.33M1.97M425.08K
Research & Development40.28M38.58M41.35M33.55M27.49M28.54M18.90M5.69M1.50M
Other Operating ExpensesN/AN/AN/AN/A64.00K165.34KN/AN/AN/A
Operating Income-51.99M-53.22M-43.71M-45.04M-36.77M-38.70M-23.23M-7.66M-1.93M
Other Expenses / Income1.26M214.43K45.90K463.91K483.00K165.34K35.0052.00N/A
Before Tax Income-50.73M-53.01M-43.67M-44.58M-36.29M-38.16M-23.23M-7.66M-1.93M
Income Tax Expenses3.27M-214.43K495.00K206.25K412.00K825.00KN/AN/AN/A
Net Income-50.73M-52.80M-44.16M-44.78M-36.70M-38.98M-23.23M-7.66M-1.93M
Interest Expenses1.25M713.82KN/AN/AN/AN/AN/AN/AN/A
Basic Shares Outstanding45.75M35.65M31.29M28.69M22.04M20.13M20.64M20.64M20.64M
Diluted Shares Outstanding45.75M35.65M31.29M28.69M22.04M20.13M20.64M20.64M20.64M
EBITDA-48.56M-50.77M-43.71M-43.99M-36.77M-37.94M-22.81M-7.46M-1.88M
EBITDA Margin-884.44%-4,076.94%-292.56%-1,394.44%-1,063.30%-3,320.19%0.00%0.00%0.00%
EBIT-46.22M-52.30M-43.67M-44.58M-36.29M-38.16M-23.23M-7.66M-1.93M
EBIT Margin-841.89%-4,199.76%-292.25%-1,413.26%-1,049.33%-3,339.33%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙